Alps Advisors Inc Neogenomics Inc Transaction History

Alps Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$30.49 - $48.49 $181,537 - $288,709	-5,954 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $54,157 - $68,276	-1,300 Reduced 17.92%	5,954 $287,000
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $9,521 - $13,439	-260 Reduced 3.46%	7,254 $328,000
Q1 2021 May 07, 2021	SELL	$41.56 - $59.88 $75,348 - $108,562	-1,813 Reduced 19.44%	7,514 $362,000
Q4 2020 Feb 03, 2021	SELL	$36.08 - $56.47 $202,011 - $316,175	-5,599 Reduced 37.51%	9,327 $502,000
Q3 2020 Nov 04, 2020	SELL	$33.26 - $40.48 $41,741 - $50,802	-1,255 Reduced 7.76%	14,926 $551,000
Q2 2020 Aug 05, 2020	SELL	$24.21 - $31.02 $170,268 - $218,163	-7,033 Reduced 30.3%	16,181 $501,000
Q1 2020 May 06, 2020	BUY	$20.5 - $34.53 $475,887 - $801,579	23,214 New	23,214 $641,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.